The company - Eisai
Eisai is a global leading research-based pharmaceutical company driven by “giving first thought to patients and their families, and increasing the benefits that health care provides”. Eisai is committed to research and development and has an exciting pipeline from new discoveries, acquired molecules and further development of licensed products within Neurology, Gastroenterology, Critical Care and Oncology. With operations in U.S., Asia, Europe and the domestic market of Japan, Eisai employs 11.000 people worldwide. The Nordic headquarter is located in Sweden, Danderyd, north of Stockholm.
Further information about the company in Europe can be found on http://www.eisai.co.uk.
The Nordic Organisation
The Nordic team consist of 28 people in total in sales and marketing, medical and finance and is expected to grow over the coming years.
The Commercial team with 11 Key Account Managers across Sweden, Norway, Denmark and Finland, three Regional Sales Managers, two Marketing Managers is lead by the Nordic Sales and Marketing Director. The KAM organisation work very closely with the medical team with four Medical Scientific Liaisons (two in Oncology and two in Neurology), and the Medical Director. The Nordic organisation has a clear focus on two therapy areas – Neurology (epilepsy) and Oncology.
About Neurology
Eisai has a unique position in Epilepsy with four products on the market. The company has a very interesting pipeline and is fully committed to maintaining a long-term position in the area of Neurology.
About Oncology
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma.
Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor. In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
For more information about the company, product portfolio and pipeline, visit https://http://www.eisai.com/index.html
Eisai is a global leading research-based pharmaceutical company driven by “giving first thought to patients and their families, and increasing the benefits that health care provides”. Eisai is committed to research and development and has an exciting pipeline from new discoveries, acquired molecules and further development of licensed products within Neurology, Gastroenterology, Critical Care and Oncology. With operations in U.S., Asia, Europe and the domestic market of Japan, Eisai employs 11.000 people worldwide. The Nordic headquarter is located in Sweden, Danderyd, north of Stockholm.
Further information about the company in Europe can be found on http://www.eisai.co.uk.
The Nordic Organisation
The Nordic team consist of 28 people in total in sales and marketing, medical and finance and is expected to grow over the coming years.
The Commercial team with 11 Key Account Managers across Sweden, Norway, Denmark and Finland, three Regional Sales Managers, two Marketing Managers is lead by the Nordic Sales and Marketing Director. The KAM organisation work very closely with the medical team with four Medical Scientific Liaisons (two in Oncology and two in Neurology), and the Medical Director. The Nordic organisation has a clear focus on two therapy areas – Neurology (epilepsy) and Oncology.
About Neurology
Eisai has a unique position in Epilepsy with four products on the market. The company has a very interesting pipeline and is fully committed to maintaining a long-term position in the area of Neurology.
About Oncology
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma.
Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor. In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
For more information about the company, product portfolio and pipeline, visit https://http://www.eisai.com/index.html
TILLSATT - Key Account Manager Neurology Finland. Eisai
Opportunity within Neurology in a leading and growing company with a great company culture
The position Key Account Manager Neurology Finland
The Key Account Manager Finland will have full responsibility for sales of the Epilepsy portfolio with a special focus on Fycompa®. There are several exciting releases, launches and activities planned in a near future. Fycompa® will come in an oral suspension form that is planned to be launched in Finland in the near future. A new paediatric indication will be approved and a new customer program will be introduced. The Key Account Manager position reports to the Regional Sales Manager Finland.
The position holds full responsibility to develop and execute the Key Account strategy and achieve targets and related Key Performance Indicators (KPIs). This means to independently make sales calls, plan and execute activities, and to build and maintain good business relationships with customers and Key Opinion Leaders in the area of Epilepsy. The position offers a unique opportunity to work with new and exciting products and launches.
Territorial responsibility
Responsibility for Neurology in Finland is shared with a colleague in the North. This role holds the responsibility for South of Finland and is preferably based in the greater Helsinki area.
Opportunities with the role
Eisai is a growing company worldwide and even more so in the Nordic and European region. In the expansion and development of the company, Eisai maintains full focus on the hhc philosophy (human health care), which means a full commitment to deliver health to patients and their families. This is reflected in the spirit and the positive culture that you find among Eisai employees. Eisai encourages employees to engage and spend time with patients to be able to truly understand patients’ situations and simply do good for patients.
Eisai is well established and has a solid reputation within Neurology and Oncology. The success is built on innovative and modern treatment alternatives adding substantial value to patients and healthcare. The future opportunities are excellent with a high value product portfolio as well as a promising pipeline.
The right candidate will be part of an experienced and professional team with a great spirit. The Key Account Manager will receive support and development from the Nordic management and from the Europe North team in London.
Eisai offers continues development for all personnel, both individual and team oriented. An individual development plan will be agreed with the line manager.
Experience and qualifications required
We are looking for an experienced Sales professional with a successful history in pharmaceutical sales. The right candidate has a good understanding of the Finnish healthcare and payor/policy environment and a good understanding and evidence of a successful KAM approach to business.
Required skills:
• Excellent selling skills
• Proactive ‘can do’ attitude
• Excellent interpersonal skills
• Experienced secondary care pharmaceutical sales background
• Ability to forecast and track territory sales
• Autonomous, assumes ownership and responsibility for delivery of agreed objectives
• Professional in customer interactions
• Commercially aware
• Excellent communication skills (written, verbal & listening)
• Analytical and business planning skills
Language skills and other:
Fluent in spoken and written Finnish, Good in English
Microsoft office (word, exel, powerpoint) and CRM software
Valid driving licence
Personal characteristics:
• Flexibility, pro-activity
• Impactful
• Diplomatic. Ability to interact with a range of personalities
• Ambitious. Strong drive and ability to work independently
• Positive “can-do” attitude
• Teamplayer that enjoys interacting and communicating with colleagues (sharing experience and best practice)
Contact
For inquires and more information about the position, please contact Magnus Klingberg or Sara Steinvall, Senior Recruitment Consultants at PeakSearch.
Apply for the position at http://www.peaksearch.se.
Contact details
Magnus Klingberg, magnus.klingberg@peaksearch.se +46 (0)70-678 09 92, +46 (0)8-545 00 100
Sara Steinvall sara.steinvall@peaksearch.se mobile: +46 (0)70-204 37 42
The Key Account Manager Finland will have full responsibility for sales of the Epilepsy portfolio with a special focus on Fycompa®. There are several exciting releases, launches and activities planned in a near future. Fycompa® will come in an oral suspension form that is planned to be launched in Finland in the near future. A new paediatric indication will be approved and a new customer program will be introduced. The Key Account Manager position reports to the Regional Sales Manager Finland.
The position holds full responsibility to develop and execute the Key Account strategy and achieve targets and related Key Performance Indicators (KPIs). This means to independently make sales calls, plan and execute activities, and to build and maintain good business relationships with customers and Key Opinion Leaders in the area of Epilepsy. The position offers a unique opportunity to work with new and exciting products and launches.
Territorial responsibility
Responsibility for Neurology in Finland is shared with a colleague in the North. This role holds the responsibility for South of Finland and is preferably based in the greater Helsinki area.
Opportunities with the role
Eisai is a growing company worldwide and even more so in the Nordic and European region. In the expansion and development of the company, Eisai maintains full focus on the hhc philosophy (human health care), which means a full commitment to deliver health to patients and their families. This is reflected in the spirit and the positive culture that you find among Eisai employees. Eisai encourages employees to engage and spend time with patients to be able to truly understand patients’ situations and simply do good for patients.
Eisai is well established and has a solid reputation within Neurology and Oncology. The success is built on innovative and modern treatment alternatives adding substantial value to patients and healthcare. The future opportunities are excellent with a high value product portfolio as well as a promising pipeline.
The right candidate will be part of an experienced and professional team with a great spirit. The Key Account Manager will receive support and development from the Nordic management and from the Europe North team in London.
Eisai offers continues development for all personnel, both individual and team oriented. An individual development plan will be agreed with the line manager.
Experience and qualifications required
We are looking for an experienced Sales professional with a successful history in pharmaceutical sales. The right candidate has a good understanding of the Finnish healthcare and payor/policy environment and a good understanding and evidence of a successful KAM approach to business.
Required skills:
• Excellent selling skills
• Proactive ‘can do’ attitude
• Excellent interpersonal skills
• Experienced secondary care pharmaceutical sales background
• Ability to forecast and track territory sales
• Autonomous, assumes ownership and responsibility for delivery of agreed objectives
• Professional in customer interactions
• Commercially aware
• Excellent communication skills (written, verbal & listening)
• Analytical and business planning skills
Language skills and other:
Fluent in spoken and written Finnish, Good in English
Microsoft office (word, exel, powerpoint) and CRM software
Valid driving licence
Personal characteristics:
• Flexibility, pro-activity
• Impactful
• Diplomatic. Ability to interact with a range of personalities
• Ambitious. Strong drive and ability to work independently
• Positive “can-do” attitude
• Teamplayer that enjoys interacting and communicating with colleagues (sharing experience and best practice)
Contact
For inquires and more information about the position, please contact Magnus Klingberg or Sara Steinvall, Senior Recruitment Consultants at PeakSearch.
Apply for the position at http://www.peaksearch.se.
Contact details
Magnus Klingberg, magnus.klingberg@peaksearch.se +46 (0)70-678 09 92, +46 (0)8-545 00 100
Sara Steinvall sara.steinvall@peaksearch.se mobile: +46 (0)70-204 37 42